Cargando…

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity

BACKGROUND: Nor-BNI, GNTI and JDTic induce κ opioid antagonism that is delayed by hours and can persist for months. Other effects are transient. It has been proposed that these drugs may be slowly absorbed or distributed, and may dissolve in cell membranes, thus slowing elimination and prolonging th...

Descripción completa

Detalles Bibliográficos
Autores principales: Munro, Thomas A, Berry, Loren M, Van’t Veer, Ashlee, Béguin, Cécile, Carroll, F Ivy, Zhao, Zhiyang, Carlezon, William A, Cohen, Bruce M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411462/
https://www.ncbi.nlm.nih.gov/pubmed/22642416
http://dx.doi.org/10.1186/1471-2210-12-5
_version_ 1782239828108115968
author Munro, Thomas A
Berry, Loren M
Van’t Veer, Ashlee
Béguin, Cécile
Carroll, F Ivy
Zhao, Zhiyang
Carlezon, William A
Cohen, Bruce M
author_facet Munro, Thomas A
Berry, Loren M
Van’t Veer, Ashlee
Béguin, Cécile
Carroll, F Ivy
Zhao, Zhiyang
Carlezon, William A
Cohen, Bruce M
author_sort Munro, Thomas A
collection PubMed
description BACKGROUND: Nor-BNI, GNTI and JDTic induce κ opioid antagonism that is delayed by hours and can persist for months. Other effects are transient. It has been proposed that these drugs may be slowly absorbed or distributed, and may dissolve in cell membranes, thus slowing elimination and prolonging their effects. Recent evidence suggests, instead, that they induce prolonged desensitization of the κ opioid receptor. METHODS: To evaluate these hypotheses, we measured relevant physicochemical properties of nor-BNI, GNTI and JDTic, and the timecourse of brain and plasma concentrations in mice after intraperitoneal administration (using LC-MS-MS). RESULTS: In each case, plasma levels were maximal within 30 min and declined by >80% within four hours, correlating well with previously reported transient effects. A strong negative correlation was observed between plasma levels and the delayed, prolonged timecourse of κ antagonism. Brain levels of nor-BNI and JDTic peaked within 30 min, but while nor-BNI was largely eliminated within hours, JDTic declined gradually over a week. Brain uptake of GNTI was too low to measure accurately, and higher doses proved lethal. None of the drugs were highly lipophilic, showing high water solubility (> 45 mM) and low distribution into octanol (log D(7.4) < 2). Brain homogenate binding was within the range of many shorter-acting drugs (>7% unbound). JDTic showed P-gp-mediated efflux; nor- BNI and GNTI did not, but their low unbound brain uptake suggests efflux by another mechanism. CONCLUSIONS: The negative plasma concentration-effect relationship we observed is difficult to reconcile with simple competitive antagonism, but is consistent with desensitization. The very slow elimination of JDTic from brain is surprising given that it undergoes active efflux, has modest affinity for homogenate, and has a shorter duration of action than nor-BNI under these conditions. We propose that this persistence may result from entrapment in cellular compartments such as lysosomes.
format Online
Article
Text
id pubmed-3411462
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34114622012-08-04 Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity Munro, Thomas A Berry, Loren M Van’t Veer, Ashlee Béguin, Cécile Carroll, F Ivy Zhao, Zhiyang Carlezon, William A Cohen, Bruce M BMC Pharmacol Research Article BACKGROUND: Nor-BNI, GNTI and JDTic induce κ opioid antagonism that is delayed by hours and can persist for months. Other effects are transient. It has been proposed that these drugs may be slowly absorbed or distributed, and may dissolve in cell membranes, thus slowing elimination and prolonging their effects. Recent evidence suggests, instead, that they induce prolonged desensitization of the κ opioid receptor. METHODS: To evaluate these hypotheses, we measured relevant physicochemical properties of nor-BNI, GNTI and JDTic, and the timecourse of brain and plasma concentrations in mice after intraperitoneal administration (using LC-MS-MS). RESULTS: In each case, plasma levels were maximal within 30 min and declined by >80% within four hours, correlating well with previously reported transient effects. A strong negative correlation was observed between plasma levels and the delayed, prolonged timecourse of κ antagonism. Brain levels of nor-BNI and JDTic peaked within 30 min, but while nor-BNI was largely eliminated within hours, JDTic declined gradually over a week. Brain uptake of GNTI was too low to measure accurately, and higher doses proved lethal. None of the drugs were highly lipophilic, showing high water solubility (> 45 mM) and low distribution into octanol (log D(7.4) < 2). Brain homogenate binding was within the range of many shorter-acting drugs (>7% unbound). JDTic showed P-gp-mediated efflux; nor- BNI and GNTI did not, but their low unbound brain uptake suggests efflux by another mechanism. CONCLUSIONS: The negative plasma concentration-effect relationship we observed is difficult to reconcile with simple competitive antagonism, but is consistent with desensitization. The very slow elimination of JDTic from brain is surprising given that it undergoes active efflux, has modest affinity for homogenate, and has a shorter duration of action than nor-BNI under these conditions. We propose that this persistence may result from entrapment in cellular compartments such as lysosomes. BioMed Central 2012-05-29 /pmc/articles/PMC3411462/ /pubmed/22642416 http://dx.doi.org/10.1186/1471-2210-12-5 Text en Copyright ©2012 Munro et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Munro, Thomas A
Berry, Loren M
Van’t Veer, Ashlee
Béguin, Cécile
Carroll, F Ivy
Zhao, Zhiyang
Carlezon, William A
Cohen, Bruce M
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
title Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
title_full Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
title_fullStr Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
title_full_unstemmed Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
title_short Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
title_sort long-acting κ opioid antagonists nor-bni, gnti and jdtic: pharmacokinetics in mice and lipophilicity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411462/
https://www.ncbi.nlm.nih.gov/pubmed/22642416
http://dx.doi.org/10.1186/1471-2210-12-5
work_keys_str_mv AT munrothomasa longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT berrylorenm longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT vantveerashlee longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT beguincecile longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT carrollfivy longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT zhaozhiyang longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT carlezonwilliama longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity
AT cohenbrucem longactingkopioidantagonistsnorbnigntiandjdticpharmacokineticsinmiceandlipophilicity